Human medicines European public assessment report (EPAR): NeoRecormon, epoetin beta, Date of authorisation: 16/07/1997, Revision: 35, Status: Authorised

Emergency Task Force (ETF) documents

PRAC-ETF considerations on the use of Ixchiq live attenuated virus vaccine against chikungunya

Organisation chart: Advisory functions

Human medicines European public assessment report (EPAR): Capecitabine Medac, capecitabine, Date of authorisation: 19/11/2012, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Xeloda, capecitabine, Date of authorisation: 02/02/2001, Revision: 31, Status: Authorised

Human medicines European public assessment report (EPAR): Eptifibatide Accord, eptifibatide, Date of authorisation: 11/01/2016, Revision: 8, Status: Authorised

Members of the Coordinating group of European network of paediatric research at the European Medicines Agency (Enpr-EMA)

Human medicines European public assessment report (EPAR): Alprolix, eftrenonacog alfa, Date of authorisation: 12/05/2016, Revision: 11, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Pirsue, pirlimycin, Date of authorisation: 29/01/2001, Status: Withdrawn